Natural Killer Cells in the Development of Asthma

Current Allergy and Asthma Reports

Volumn 15, Issue 2, 2015, Pages 1-8

  Mathias, Clinton B ^a  

^a WESTERN NEW ENGLAND UNIVERSITY   (United States)

Author keywords

Allergic inflammation; Asthma; Natural killer cells; NK2; NKG2D

Indexed keywords

ASTHMA; CELL FUNCTION; CELL MATURATION; CYTOLOGY; DISEASE COURSE; HUMAN; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; REVIEW; SENSITIZATION; T LYMPHOCYTE ACTIVATION; ANIMAL; IMMUNOLOGY; T LYMPHOCYTE;

ALLERGEN; CYTOKINE;

ALLERGENS; ANIMALS; ASTHMA; CYTOKINES; HUMANS; KILLER CELLS, NATURAL; PHENOTYPE; T-LYMPHOCYTES;

EID: 84919331247     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-014-0500-2     Document Type: Review

References (96)

1. Walker C, Kaegi MK, Braun P, Blaser K. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol. 1991;88(6):935–42.
2. Azzawi M, Johnston PW, Majumdar S, Kay AB, Jeffery PK. T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis. Am Rev Respir Dis. 1992;145(6):1477–82.
3. Virchow Jr JC, Walker C, Hafner D, Kortsik C, Werner P, Matthys H, et al. T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma. Am J Respir Crit Care Med. 1995;151(4):960–8.
4. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol. 1999;17:255–81.
5. Lee NA, Gelfand EW, Lee JJ. Pulmonary T cells and eosinophils: coconspirators or independent triggers of allergic respiratory pathology? J Allergy Clin Immunol. 2001;107(6):945–57.
6. Hamelmann E, Gelfand EW. IL-5-induced airway eosinophilia—the key to asthma? Immunol Rev. 2001;179:182–91.
7. Oettgen HC, Geha RS. IgE regulation and roles in asthma pathogenesis. J Allergy Clin Immunol. 2001;107(3):429–40.
8. Lambrecht BN, Hammad H. Taking our breath away: dendritic cells in the pathogenesis of asthma. Nat Rev Immunol. 2003;3(12):994–1003.
9. Lambrecht BN, Hammad H. The other cells in asthma: dendritic cell and epithelial cell crosstalk. Curr Opin Pulm Med. 2003;9(1):34–41.
10. Wills-Karp M, Chiaramonte M. Interleukin-13 in asthma. Curr Opin Pulm Med. 2003;9(1):21–7.
11. Wills-Karp Marsha H. Immunological mechanisms of allergic disorders. In: Paul W, editor. Fundamental immunology. Philadelphia: Lippincott-Raven Publishers; 2003. p. 1439–79.
12. Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol. 2004;22:789–815.
13. Wills-Karp M, Ewart SL. Time to draw breath: asthma-susceptibility genes are identified. Nat Rev Genet. 2004;5(5):376–87.
14. Frieri M. Asthma concepts in the new millennium: update in asthma pathophysiology. Allergy Asthma Proc. 2005;26(2):83–8.
15. Frieri M. Advances in the understanding of allergic asthma. Allergy Asthma Proc. 2007;28(6):614–9. doi:10.2500/Aap.2007.28.2952.
16. Medoff BD, Thomas SY, Luster AD. T cell trafficking in allergic asthma: the ins and outs. Annu Rev Immunol. 2008;26:205–32. doi:10.1146/Annurev.Immunol.26.021607.090312.
17. Kim HY, Dekruyff RH, Umetsu DT. The many paths to asthma: phenotype shaped by innate and adaptive immunity. Nat Immunol. 2010;11(7):577–84. doi:10.1038/Ni.1892.
18. Holgate S. Innate and adaptive immune responses in asthma. Nat Med. 2012;18(5):673–83. doi:10.1038/Nm.2731. A Recent Review Detailing The Role Of Innate And Adaptive Immune Cells In Asthma.
19. Lund S, Walford HH, Doherty TA. Type 2 innate lymphoid cells in allergic disease. Curr Immunol Rev. 2013;9(4):214–21. doi:10.2174/1573395510666140304235916.
20. Holtzman MJ, Byers DE, Alexander-Brett J, Wang X. The role of airway epithelial cells and innate immune cells in chronic respiratory disease. Nat Rev Immunol. 2014;14(10):686–98. doi:10.1038/Nri3739.
21. Korsgren M, Persson CG, Sundler F, Bjerke T, Hansson T, Chambers BJ, et al. Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice. J Exp Med. 1999;189(3):553–62.
22. Mathias CB, Guernsey LA, Zammit D, Brammer C, Wu C, Thrall RS, et al. Pro-inflammatory role of natural killer cells in the development of allergic airway disease. Clin Exp Allergy. 2014;44(4):589–601. doi:10.1111/Cea.12271. This Article Demonstrates That NK Cells Are Recruited To The Allergic Airways, And That In The Absence Of NK Cells, In NK-Deficient Mice Or Mice Depleted Of NK Cell Subsets, Airway Inflammation Is Attenuated. It Also Shows That NK Cells Are Required At Priming, And That NK Cells Regulate The Number Of Dendritic Cells In Spleens And Lungs Of Allergic Mice.
23. Ple C, Barrier M, Amniai L, Marquillies P, Bertout J, Tsicopoulos A, et al. Natural killer cells accumulate in lung-draining lymph nodes and regulate airway eosinophilia in a murine model of asthma. Scand J Immunol. 2010;72(2):118–27. doi:10.1111/J.1365-3083.2010.02419.X. This Article Demonstrates That NK Cells Are Recruited To The Lung-Draining Lymph Nodes Of Allergic Mice, And That They Are Required During The Challenge Phase Of The Airway Response, As Shown By Depleting NK Cells Using The Anti-Asialo GM 1 Antibody.
24. Farhadi N, Lambert L, Triulzi C, Openshaw PJ, Guerra N, Culley FJ. Natural killer cell NKG2D and granzyme B are critical for allergic pulmonary inflammation. J Allergy Clin Immunol. 2014;133(3):827–35 E3. doi:10.1016/J.Jaci.2013.09.048. This Article Demonstrates That NKG2D-Deficient Mice Were Resistant To The Induction Of Eosinophilia And Exhibited Decreased Eosinophilia And IgE Production. Furthermore, Adoptive Transfer Of NK Cells Only Reconstituted Disease If The NK Cells Expressed GranzymeB.
25. Akbari O, Stock P, Meyer E, Kronenberg M, Sidobre S, Nakayama T, et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med. 2003;9(5):582–8.
26. Akbari O, Faul JL, Hoyte EG, Berry GJ, Wahlstrom J, Kronenberg M, et al. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N Engl J Med. 2006;354(11):1117–29. doi:10.1056/Nejmoa053614.
27. Koh YI, Shim JU, Lee JH, Chung IJ, Min JJ, Rhee JH, et al. Natural killer T cells are dispensable in the development of allergen-induced airway hyperresponsiveness, inflammation and remodelling in a mouse model of chronic asthma. Clin Exp Immunol. 2010;161(1):159–70. doi:10.1111/J.1365-2249.2010.04151.X.
28. Shim JU, Koh YI. Increased Th2-like invariant natural killer T cells in peripheral blood from patients with asthma. Allergy Asthma Immunol Res. 2014;6(5):444–8. doi:10.4168/Aair.2014.6.5.444.
29. Schramm CM, Puddington L, Yiamouyiannis CA, Lingenheld EG, Whiteley HE, Wolyniec WW, et al. Proinflammatory roles of T-cell receptor (TCR)gammadelta and TCRalphabeta lymphocytes in a murine model of asthma. Am J Respir Cell Mol Biol. 2000;22(2):218–25.
30. Chang YJ, Kim HY, Albacker LA, Baumgarth N, Mckenzie AN, Smith DE, et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol. 2011;12(7):631–8. doi:10.1038/Ni.2045.
31. Kim HY, Chang YJ, Subramanian S, Lee H, Albacker LA, Matangkasombut P, et al. Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. J Allergy Clin Immunol. 2012;129(1):216–27 E1-6. doi:10.1016/J.Jaci.2011.10.036.
32. Chang YJ, Dekruyff RH, Umetsu DT. The role of type 2 innate lymphoid cells in asthma. J Leukoc Biol. 2013;94(5):933–40. doi:10.1189/Jlb.0313127.
33. Yu S, Kim HY, Chang YJ, Dekruyff RH, Umetsu DT. Innate lymphoid cells and asthma. J Allergy Clin Immunol. 2014;133(4):943–50. doi:10.1016/J.Jaci.2014.02.015.
34. Biron CA. Activation and function of natural killer cell responses during viral infections. Curr Opin Immunol. 1997;9(1):24–34.
35. Yokoyama WM, Kim S, French AR. The dynamic life of natural killer cells. Annu Rev Immunol. 2004;22:405–29.
36. Cooper MA, Colonna M, Yokoyama WM. Hidden talents of natural killers: NK cells in innate and adaptive immunity. EMBO Rep. 2009;10(10):1103–10. doi:10.1038/Embor.2009.203. This Important Review Details The Role Of NK Cells In Various Innate And Adaptive Immune Responses.
37. Natarajan K, Dimasi N, Wang J, Mariuzza RA, Margulies DH. Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. Annu Rev Immunol. 2002;20:853–85.
38. Raulet DH. Natural killer cells. In: Paul WE, editor. Fundamental immunology. Philadelphia: Lippincott-Raven Publishers; 2003. p. 365–91.
39. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol. 2001;22(11):633–40.
40. Colucci F, Caligiuri MA, Di Santo JP. What does it take to make a natural killer? Nat Rev Immunol. 2003;3(5):413–25.
41. Di Santo JP. Functionally distinct NK-cell subsets: developmental origins and biological implications. Eur J Immunol. 2008;38(11):2948–51. doi:10.1002/Eji.200838830.
42. Fehniger TA, Caligiuri MA. Interleukin 15: biology and relevance to human disease. Blood. 2001;97(1):14–32.
43. Dokun AO, Kim S, Smith HR, Kang HS, Chu DT, Yokoyama WM. Specific and nonspecific NK cell activation during virus infection. Nat Immunol. 2001;2(10):951–6.
44. Koka R, Burkett PR, Chien M, Chai S, Chan F, Lodolce JP, et al. Interleukin (IL)-15R[alpha]-deficient natural killer cells survive in normal but not IL-15R[alpha]-deficient mice. J Exp Med. 2003;197(8):977–84.
45. Prlic M, Blazar BR, Farrar MA, Jameson SC. In vivo survival and homeostatic proliferation of natural killer cells. J Exp Med. 2003;197(8):967–76.
46. Ranson T, Vosshenrich CA, Corcuff E, Richard O, Muller W, Di Santo JP. IL-15 is an essential mediator of peripheral NK-cell homeostasis. Blood. 2003;101(12):4887–93.
47. Ranson T, Vosshenrich CA, Corcuff E, Richard O, Laloux V, Lehuen A, et al. IL-15 availability conditions homeostasis of peripheral natural killer T cells. Proc Natl Acad Sci U S A. 2003;100(5):2663–8.
48. Biron CA, Brossay L. NK cells and NKT cells in innate defense against viral infections. Curr Opin Immunol. 2001;13(4):458–64.
49. Lanier LL. On guard—activating NK cell receptors. Nat Immunol. 2001;2(1):23–7.
50. Lanier LL. Natural killer cell receptor signaling. Curr Opin Immunol. 2003;15(3):308–14.
51. Narni-Mancinelli E, Chaix J, Fenis A, Kerdiles YM, Yessaad N, Reynders A, et al. Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor. Proc Natl Acad Sci U S A. 2011;108(45):18324–9. doi:10.1073/Pnas.1112064108.
52. Raulet D. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol. 2003;3(10):781–90.
53. Vivier E, Anfossi N. Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nat Rev Immunol. 2004;4(3):190–8.
54. Yokoyama WM, Plougastel BF. Immune functions encoded by the natural killer gene complex. Nat Rev Immunol. 2003;3(4):304–16.
55. Raulet D. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol. 2004;5(10):996–1002.
56. Trinchieri G. Biology of natural killer cells. Adv Immunol. 1989;47:187–376.
57. Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman R, Munz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med. 2002;195(3):343–51.
58. Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med. 2002;195(3):327–33.
59. Piccioli D, Sbrana S, Melandri E, Valiante NM. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med. 2002;195(3):335–41.
60. Andrews DM, Scalzo AA, Yokoyama WM, Smyth MJ, Degli-Esposti MA. Functional interactions between dendritic cells and NK cells during viral infection. Nat Immunol. 2003;4(2):175–81.
61. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol. 2002;2(12):957–64.
62. Kos FJ. Regulation of adaptive immunity by natural killer cells. Immunol Res. 1998;17(3):303–12.
63. Su HC, Nguyen KB, Salazar-Mather TP, Ruzek MC, Dalod MY, Biron CA. NK cell functions restrain T cell responses during viral infections. Eur J Immunol. 2001;31(10):3048–55.
64. Diefenbach A, Jensen ER, Jamieson AM, Raulet DH. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature. 2001;413(6852):165–71.
65. Diefenbach A, Raulet D. The innate immune response to tumors and its role in the induction of T-cell immunity. Immunol Rev. 2002;188:9–21.
66. Karimi K, Forsythe P. Natural killer cells in asthma. Front Immunol. 2013;4:159. doi:10.3389/Fimmu.2013.00159. This Review Examines The Role Of NK Cells In Asthma And Discusses The Potential Of Modulating NK Cell Function As A Treatment Strategy.
67. Timonen T, Stenius-Aarniala B. Natural killer cell activity in asthma. Clin Exp Immunol. 1985;59(1):85–90.
68. Jira M, Antosova E, Vondra V, Strejcek J, Mazakova H, Prazakova J. Natural killer and interleukin-2 induced cytotoxicity in asthmatics. I. Effect of acute antigen-specific challenge. Allergy. 1988;43(4):294–8.
69. Krejsek J, Kral B, Vokurkova D, Derner V, Touskova M, Parakova Z, et al. Decreased peripheral blood gamma delta T cells in patients with bronchial asthma. Allergy. 1998;53(1):73–7.
70. Vesterinen E, Timonen T. Natural killer cell activity in specific and non-specific bronchial challenge. Ann Allergy. 1988;60(3):247–9.
71. Lin SJ, Chang LY, Yan DC, Huang YJ, Lin TJ, Lin TY. Decreased intercellular adhesion molecule-1 (CD54) and L-selectin (CD62L) expression on peripheral blood natural killer cells in asthmatic children with acute exacerbation. Allergy. 2003;58(1):67–71.
72. Means-Markwell M, Burgess T, Dekeratry D, O’neil K, Mascola J, Fleisher T, et al. Eosinophilia with aberrant T cells and elevated serum levels of interleukin-2 and interleukin-15. N Engl J Med. 2000;342(21):1568–71.
73. Werfel T, Boeker M, Kapp A. Rapid expression of the CD69 antigen on T cells and natural killer cells upon antigenic stimulation of peripheral blood mononuclear cell suspensions. Allergy. 1997;52(4):465–9.
74. Kusaka Y, Sato K, Zhang Q, Morita A, Kasahara T, Yanagihara Y. Association of natural killer cell activity with serum IgE. Int Arch Allergy Immunol. 1997;112(4):331–5.
75. Sin B, Misirligil Z, Aybay C, Gurbuz L, Imir T. Effect of allergen specific immunotherapy (IT) on natural killer cell activity (NK), IgE, IFN-gamma levels and clinical response in patients with allergic rhinitis and asthma. J Investig Allergol Clin Immunol. 1996;6(6):341–7.
76. Korsgren M. NK cells and asthma. Curr Pharm Des. 2002;8(20):1871–6.
77. Lundahl J, Hansson M. Natural killer cells in the airways: do they matter? Allergy. 2003;58(1):2–4.
78. Lisbonne M, Diem S, De Castro KA, Lefort J, Araujo LM, Hachem P, et al. Cutting edge: invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J Immunol. 2003;171(4):1637–41.
79. Kim S, Iizuka K, Aguila HL, Weissman IL, Yokoyama WM. In vivo natural killer cell activities revealed by natural killer cell-deficient mice. Proc Natl Acad Sci U S A. 2000;97(6):2731–6.
80. Bogen SA, Fogelman I, Abbas AK. Analysis of IL-2, IL-4, and IFN-gamma-producing cells in situ during immune responses to protein antigens. J Immunol. 1993;150(10):4197–205.
81. Carnaud C, Lee D, Donnars O, Park S, Beavis A, Koezuka Y, et al. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol. 1999;163(9):4647–50.
82. Mehrotra PT, Donnelly RP, Wong S, Kanegane H, Geremew A, Mostowski HS, et al. Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12. J Immunol. 1998;160(6):2637–44.
83. Warren HS, Kinnear BF, Phillips JH, Lanier LL. Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12. J Immunol. 1995;154(10):5144–52.
84. Hoshino T, Winkler-Pickett RT, Mason AT, Ortaldo JR, Young HA. IL-13 production by NK cells: IL-13-producing NK and T cells are present in vivo in the absence of IFN-gamma. J Immunol. 1999;162(1):51–9.
85. Hoshino T, Wiltrout RH, Young HA. IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. J Immunol. 1999;162(9):5070–7.
86. Walker C, Checkel J, Cammisuli S, Leibson PJ, Gleich GJ. IL-5 production by NK cells contributes to eosinophil infiltration in a mouse model of allergic inflammation. J Immunol. 1998;161(4):1962–9.
87. Peritt D, Robertson S, Gri G, Showe L, Aste-Amezaga M, Trinchieri G. Differentiation of human NK cells into NK1 and NK2 subsets. J Immunol. 1998;161(11):5821–4.
88. Deniz G, Akdis M, Aktas E, Blaser K, Akdis CA. Human NK1 and NK2 subsets determined by purification of IFN-gamma-secreting and IFN-gamma-nonsecreting NK cells. Eur J Immunol. 2002;32(3):879–84.
89. Wei H, Zhang J, Xiao W, Feng J, Sun R, Tian Z. Involvement of human natural killer cells in asthma pathogenesis: natural killer 2 cells in type 2 cytokine predominance. J Allergy Clin Immunol. 2005;115(4):841–7. doi:10.1016/J.Jaci.2004.11.026.
90. Wingett D, Nielson CP. Divergence in NK cell and cyclic amp regulation of T cell CD40L expression in asthmatic subjects. J Leukoc Biol. 2003;74(4):531–41. doi:10.1189/Jlb.0303103.
91. Kaiko GE, Phipps S, Angkasekwinai P, Dong C, Foster PS. NK cell deficiency predisposes to viral-induced Th2-type allergic inflammation via epithelial-derived IL-25. J Immunol. 2010;185(8):4681–90. doi:10.4049/Jimmunol.1001758.
92. Scordamaglia F, Balsamo M, Scordamaglia A, Moretta A, Mingari MC, Canonica GW, et al. Perturbations of natural killer cell regulatory functions in respiratory allergic diseases. J Allergy Clin Immunol. 2008;121(2):479–85. doi:10.1016/J.Jaci.2007.09.047.
93. Arase N, Arase H, Hirano S, Yokosuka T, Sakurai D, Saito T. IgE-mediated activation of NK cells through Fc gamma RIII. J Immunol. 2003;170(6):3054–8.
94. Vosskuhl K, Greten TF, Manns MP, Korangy F, Wedemeyer J. Lipopolysaccharide-mediated mast cell activation induces IFN-gamma secretion by NK cells. J Immunol. 2010;185(1):119–25. doi:10.4049/Jimmunol.0902406.
95. Ferlazzo G, Morandi B. Cross-talks between natural killer cells and distinct subsets of dendritic cells. Front Immunol. 2014;5:159. doi:10.3389/Fimmu.2014.00159.
96. Haworth O, Cernadas M, Levy BD. NK cells are effectors for resolvin E1 in the timely resolution of allergic airway inflammation. J Immunol. 2011;186(11):6129–35. doi:10.4049/Jimmunol.1004007. This Article Demonstrates A Role For NK Cells In The Clearance Of Eosinophil And Antigen-Specific T Cells After The Cessation Of Allergic Responses. NK Cells In The Model Express The Receptor For Resolvin E1, Which Regulated NK Cell Migration And Cytotoxicity During The Resolution Of The Response.